OPRK1

Gène de l'espèce Homo sapiens

The κ-opioid receptor or kappa opioid receptor, abbreviated KOR or KOP for its ligand ketazocine, is a G protein-coupled receptor that is encoded by the OPRK1 gene in humans. The KOR is coupled to the G protein Gi/G0 and is among related receptors that bind opioid-like compounds in the brain and are responsible for mediating the effects of these compounds.

Nº Q14897645 ★

Commune · Savoirs

OPRK1

Gène de l'espèce Homo sapiens

Texte en anglais

The κ-opioid receptor or kappa opioid receptor, abbreviated KOR or KOP for its ligand ketazocine, is a G protein-coupled receptor that is encoded by the OPRK1 gene in humans. The KOR is coupled to the G protein Gi/G0 and is among related receptors that bind opioid-like compounds in the brain and are responsible for mediating the effects of these compounds.

Dernier prix

—

Prix plancher

—

Médiane 7 j

—

Ventes 30 j

0

Fourchette 30 j

—

En circulation

0

Cours

Voir le tableau
Datemédiane MinMaxventes

Historique des ventes

Dernière vente
—
Moyenne 30 j
—
Plus bas 30 j
—
Plus haut 30 j
—
Ventes 7 j
0
Ventes 30 j
0

Aucune vente pour l'instant.

Ventes anonymes : ni acheteur ni vendeur. Les chiffres ne comptent que les ventes entre joueurs.

Sur Wikipédia

Texte en anglais Pas encore d'article dans ta langue : extrait en anglais.

The κ-opioid receptor or kappa opioid receptor, abbreviated KOR or KOP for its ligand ketazocine, is a G protein-coupled receptor that is encoded by the OPRK1 gene in humans. The KOR is coupled to the G protein Gi/G0 and is among related receptors that bind opioid-like compounds in the brain and are responsible for mediating the effects of these compounds. These include altering nociception, mood, reward system, and motor control. KOR is one of the two opioid receptors that bind dynorphin opioid peptides as the primary endogenous ligands, the other being newly deorphanized GPR139 receptor. In addition, oxytocin was found to be a positive allosteric modulator of KOR, and a variety of natural alkaloids, terpenoids, and synthetic ligands bind to the receptor. Dysregulation of this receptor system has been implicated in multiple psychiatric disorders including: depressive and anxiety disorders, disorders of diminished motivation, schizophrenia, borderline personality disorder, bipolar disorder, and substance use disorder. Ligands binding to the receptor have been approved the treatment of pruritus and pain management. Aside from those indications they are investigated for various psychiatric disorders, irritable bowel syndrome, and acute stroke.

Texte : Wikipédia en anglais, CC BY-SA 4.0. · Image : Boghog (CC BY-SA 3.0) ·

Cartes voisines

Voir la fiche

Confirmation